Shell (SHEL) Q4 2025 earnings review
Cash Engine Sputters on Downstream Weakness
Shell ended 2025 with a sequential thud. Adjusted Earnings fell 40% QoQ to $3.3B, missing the resilience seen earlier in the year. The culprit was a total collapse in downstream profitability: Chemicals & Products swung to a loss, and Marketing earnings halved. While Upstream production remains a bright spot (+3% volume), the 'performance' narrative took a hit from $1.1B in impairments. Despite the earnings air pocket, the cash machine is intact ($9.4B CFFO), giving management confidence to hike the dividend 4% and reload the $3.5B buyback cannon.
🐂 Bull Case
Cash flow remains sufficient to fund a 4% dividend increase (to $0.372) and another $3.5B buyback. The yield thesis remains the primary reason to own the stock.
Production grew 3% QoQ to 1.89M boe/d, driven by ramp-ups in Canada and lower maintenance. This segment remains the reliable profit engine ($1.6B earnings).
🐻 Bear Case
Chemicals & Products swung from a $550M profit in Q3 to a $66M loss in Q4. Marketing earnings collapsed 56% QoQ. The diversification strategy failed to hedge lower oil/gas prices this quarter.
Shell took $1.1B in pre-tax impairments (mostly in Marketing and Chemicals), signaling that the 'portfolio simplification' isn't finished and carrying values are still too high.
⚖️ Verdict: ⚪
Neutral. The operational miss in downstream is ugly, but the balance sheet fortress and increased cash returns put a high floor under the stock price.
Key Themes
Chemicals & Products Profitability Shock
Reversing. The downstream segment was a disaster in Q4. Adjusted Earnings for Chemicals & Products swung to a loss of $66M, down from a $550M profit in Q3. Management blamed lower trading results and weak margins. This validates the 'deep trough' concerns raised in Q3, but the speed of the decline is alarming.
Integrated Gas Deceleration
Decelerating. Adjusted Earnings dropped 23% QoQ to $1.66B. While liquefaction volumes actually rose (+7% to 7.81MT), profitability was squeezed by unfavorable tax movements ($260M impact) and lower realized prices. The 'trading premium' that bolstered Q3 results evaporated in Q4.
Upstream Production Growth
Accelerating. Upstream production rose 3% QoQ to 1,892 kboe/d, driven by ramp-ups in Canada and lower maintenance. Despite lower realized oil prices (-$5/bbl impact), the segment limited its earnings decline to 13% QoQ through volume gains and lower write-offs.
Commitment to Distributions
Stable. Despite the earnings miss, Shell flexed its balance sheet. Dividend increased 4% to $0.372/share. A new $3.5B buyback program was launched. With gearing at 20.7%, management clearly views the stock as undervalued relative to the underlying cash generation.
Impairment Charges
A net gain of $1.2B in identified items masks a $1.0B impairment charge. While divestment gains (Adura JV) boosted reported Net Income, the underlying business took hits in Marketing ($527M) and Chemicals ($187M), suggesting carrying values for these assets remain problematic in the current macro environment.
Other KPIs
Decelerating. Down from $12.2B in Q3 and $13.2B a year ago. Working capital provided a $1.3B inflow, but this was offset by $2.6B in tax payments. This level covers CapEx ($6.0B) and Dividends ($2.1B), but relies on balance sheet cash to fund the full buyback.
Decelerating. Collapsed from $1.3B in Q3 (-56%). Management cited seasonal volume declines and lower margins. This breaks the recent trend of Marketing acting as a stable counter-cyclical buffer.
Accelerating. Increased from $41.2B in Q3. Gearing tick up to 20.7% from 18.8%. While still healthy, the trend of deleveraging has reversed as cash returns outpaced free cash flow in the quarter.
Guidance
Stable. Midpoint (950) is roughly flat vs Q4 actuals (934). Suggests no major maintenance impacts or new ramp-ups in the immediate quarter.
Stable. Midpoint (7.7) is slightly below Q4 actuals (7.81). implies the 'ramp-up' benefit from LNG Canada seen in Q4 is now in the base rate.
Decelerating. Midpoint (1,800) is down 5% vs Q4 actuals (1,892). This suggests planned maintenance or natural decline will weigh on volumes to start the year.
Stable. Unchanged from FY25 guidance range (actual FY25 was $20.9B). Management is keeping the purse strings tight despite the earnings volatility.
Key Questions
Chemicals Turnaround Timeline
Chemicals & Products swung to a loss this quarter. Is this the bottom of the 'deep trough' mentioned in Q3, or should investors expect negative contributions through 2026?
Trading Normalization
Integrated Gas earnings dropped 23% despite higher volumes. Has the trading premium fully evaporated, and is $1.6B the new quarterly run-rate for this segment?
Marketing Margin Compression
Marketing earnings halved sequentially. How much of this was pure seasonality versus a structural squeeze in retail margins?
Gearing Comfort Level
Net debt rose and gearing crossed 20%. With buybacks outpacing FCF this quarter, at what gearing level does the buyback pace need to slow?